<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01194778</url>
  </required_header>
  <id_info>
    <org_study_id>08-3-078</org_study_id>
    <nct_id>NCT01194778</nct_id>
  </id_info>
  <brief_title>Comparison of Efficacy of Different Dosages Vitamin K2</brief_title>
  <official_title>Comparison of Efficacy of Different Dosages Vitamin K2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin K is a group name for a number of compounds: K1 is present in chloroplasts in green
      vegetables, K2 is of microbial origin. Lactic bacteria produce a mixture of higher
      menaquinones, including menaquinone-7, menaquinone-8, and menaquinone-9. Nothing is known yet
      about the efficacy of bacterial K2 vitamins for in vivo K function (carboxylation of
      essential proteins). Therefore, this study was undertaken to study effects of different
      dosages of bacterial vitamin K2 on carboxylation of extrahepatic proteins.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin K is a group name for a number of compounds: K1 is present in chloroplasts in green
      vegetables, K2 is of microbial origin. Lactic bacteria produce a mixture of higher
      menaquinones, including menaquinone-7, menaquinone-8, and menaquinone-9. Higher menaquinones
      not only have very long half-life times (over 3 days rather than 1 hour for vitamin K1); K2
      vitamins are also transported to extra hepatic tissues such as bone and vessel wall whereas
      K1 is preferentially transported to the liver. Nothing is known yet about the efficacy of
      bacterial K2 vitamins for in vivo K function (carboxylation of essential proteins). This
      study describes a dose-response experiment for different dosages of bacterial K2 which are
      compared with one selected dose of K1 and placebo. The efficacy is concluded from the
      carboxylation of the bone Gla-protein osteocalcin and of the vascular Gla-protein matrix-Gla
      protein (MGP).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The concentration of the circulating biochemical markers matrix-Gla protein and osteocalcin. Both proteins will be measured in their active form (carboxylated form) and their inactive form (undercarboxylated form).</measure>
    <time_frame>12 weeks</time_frame>
    <description>The main purpose of the study is to investigate the efficacy of different dosages bacterial vitamin K2 and vitamin K1 on carboxylation degree of the vitamin K-dependent proteins osteocalcin and matrix-gla protein.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the number or type of bacteria in the stool</measure>
    <time_frame>12 weeks</time_frame>
    <description>The second purpose of the study is to monitor whether the increased vitamin K intake will change the composition of the intestinal flora, as measured from the collected stools. Vitamin K, notably K2 is produced by a number of colonic bacteria and our principal is interested to learn whether the intake of extra vitamin K will affect the number or type of bacteria in the stool.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Carboxylation Level</condition>
  <condition>Vitamin K-dependent Proteins</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The participants of the placebo group will receive daily 1 placebo sachet containing only sucrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin K1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants of this group will receive daily 1 sachet containing 15 µg vitamin K1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin K2 - 15 µg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants of this group will receive daily 1 sachet containing 15 µg vitamin K2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin K2 - 30 µg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants of this group will receive daily 1 sachet containing 30 µg vitamin K2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin K2 - 45 µg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants of this group will receive daily 1 sachet containing 45 µg vitamin K2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>1 placebo sachet per day containing only sucrose during 12 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin K1</intervention_name>
    <description>15 µg vitamin K1 per day during 12 weeks</description>
    <arm_group_label>vitamin K1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin K2</intervention_name>
    <description>15 µg vitamin K2 per day during 12 weeks</description>
    <arm_group_label>vitamin K2 - 15 µg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin K2</intervention_name>
    <description>30 µg vitamin K2 per day during 12 weeks</description>
    <arm_group_label>vitamin K2 - 30 µg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin K2</intervention_name>
    <description>45 µg vitamin K2 per day during 12 weeks</description>
    <arm_group_label>vitamin K2 - 45 µg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women between 40 and 60 years old

          -  Subjects of normal body weight and height according to BMI &lt; 30

          -  Subjects of Caucasian race

          -  Subject has given written consent to take part in the study

        Exclusion Criteria:

          -  Subjects with (a history of) metabolic or gastrointestinal disease

          -  Subjects presenting chronic degenerative and/or inflammatory disease

          -  Subjects presenting diabetes mellitus

          -  Abuse of drugs and/or alcohol

          -  Subjects receiving corticoϊd treatment including inhalators

          -  Subjects using oral anticoagulants

          -  Subjects using vitamin K containing multivitamins or vitamin K supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cees Vermeer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VitaK BV Maastricht University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VitaK BV Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 EV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2010</study_first_submitted>
  <study_first_submitted_qc>September 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2010</study_first_posted>
  <last_update_submitted>September 2, 2010</last_update_submitted>
  <last_update_submitted_qc>September 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. C. Vermeer</name_title>
    <organization>Maastricht UMC</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin K</mesh_term>
    <mesh_term>Vitamin K 2</mesh_term>
    <mesh_term>Vitamin K 1</mesh_term>
    <mesh_term>Vitamin MK 7</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

